🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to determine the effect of food versus a faste...
Status
Completed
Location
Dana-Farber Harvard Cancer Care
Start Date
2000-05
Trial ID
NCT00437437
Treatments Being Tested
This is a Phase 2, Open-label, Randomized, Multicenter Study to Investigate...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2017-05-17
Trial ID
NCT03516071
Treatments Being Tested
Part 1: To define the recommended dose of brivanib that can be safely admin...
Status
Completed
Location
Usc/Norris Comprehensive Cancer Center Hospital
Start Date
2008-05
Trial ID
NCT00594984
Treatments Being Tested
This study consists of two parts: Phase I is a dose escalation study to det...
Status
Terminated
Location
Prince of Wales Hospital
Start Date
2020-04-20
Trial ID
NCT04212221
Treatments Being Tested
This is a phase I dose escalation study to determine the safety, pharmacoki...
Status
Completed
Location
Usc/Norris Comprehensive Cancer Center
Start Date
2006-01
Trial ID
NCT00207051
Treatments Being Tested
RATIONALE: Brivanib may stop the growth of tumor cells by blocking some of ...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-05-12
Trial ID
NCT00640471
Treatments Being Tested
The purpose of this trial is to determine the mass balance, pharmacokinetic...
Status
Completed
Location
Cleveland Clinic Foundation
Start Date
2007-09
Trial ID
NCT00435669